相关实验视频

Updated: Jan 15, 2026

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis

Published on: August 29, 2025

罕见病患者护照:试点研究结果

Jo Balfour¹, Vaila Morrison¹, Lydia Seed²

¹Cambridge Rare Disease Network, Cambridge, UK.

European journal of human genetics : EJHG

|October 14, 2025

概括

针对罕见疾病的新型患者护照改善了患者,护理人员和医疗保健专业人员 (HCP) 之间的沟通. 这种共同设计的工具可以简化护理协调,并提高患者对管理复杂健康需求的信心.

科学领域:

医疗保健服务研究医疗服务研究
患者倡导患者倡导
罕见疾病管理罕见疾病管理

背景情况:

患有罕见疾病的个人经常面临由于复杂的多学科需求而分散的医疗保健.
患者,护理人员和医疗保健专业人员 (HCP) 之间的沟通挑战可能导致护理分离.
现有的患者支持工具不能充分解决罕见病患者的多方面的需求.

研究的目的:

评估一种针对罕见病患者的新型,共同设计的患者护照的实用性和影响.
评估护照在改善沟通和医疗保健协调方面的有效性.
为了衡量患者,护理人员和HCP对护照的好处的看法.

主要方法:

一项试点服务评估,涉及与患者和医疗人员共同设计的罕见疾病患者护照.
对患者/护理人员进行的干预前后调查,评估沟通和护理经验.
为医疗人员进行调查,以评估他们对护照实用性和好处的看法.

主要成果:

高比例的预护照受访者报告说,在解释医疗需求和沟通护理要求方面存在重大挑战.
通过护照后,大多数用户报告说,与不熟悉的团队进行沟通变得更容易,信心增加,并改善了获得护理的机会.
患者发现护照比现有工具更有用,并且很可能会推它.
医疗保健人员认为有很多好处,特别是在加强沟通方面,有些人建议正式认可.

结论:

特定于罕见疾病的患者护照有效地缓解了患者,护理人员和医疗人员之间的沟通障碍.
护照增强了医疗保健协调,并对患者体验产生了积极的影响.
广泛的整合得到了用户参与和积极建议的支持;建议进一步评估和正式认可.

更多相关视频

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

Published on: August 20, 2019

Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides

Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides

Published on: May 7, 2020

相关概念视频

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...

Preclinical Development: Overview

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...

Bioequivalence studies: Biowaivers

Bioequivalence studies: Biowaivers

Body:In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...